FDA Orange Book · active-ingredient family
Amlodipine besylate; benazepril hydrochloride
Amlodipine besylate; benazepril hydrochloride is approved as 1 brand and 12 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:LOTREL · NDA 020364
1
Brand (NDA)
12
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · capsule
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| LOTRELRLD×6 | SANDOZ | NDA 020364 | — | Mar 03, 1995 |
Generic (ANDA) products (12)
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Amlodipine besylate; benazepril hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

